The importance of peripheral immune cells in inflammatory bowel disease

Turkish Journal of Gastroenterology

Volumn 18, Issue 2, 2007, Pages 82-88

  Alkim, Canan ^a   Balci, Mustafa ^a   Alkim, Hüeyin ^a   Daǧli, Ülkü ^a   Parlak, Erkan ^a   Tezel, Ahmet ^a   Ülker, Aysel ^a  

^a TURKIYE YUKSEK IHTISAS HOSPITAL   (Turkey)

Author keywords

CD subtypes; Crohn's disease; Inflammatory bowel disease; Lymphocytes; Peripheral blood; Phagocytes; Ulcerative colitis

Indexed keywords

CD11B ANTIGEN; CD2 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD8 ANTIGEN; GLYCOPROTEIN P 15095; HLA DR ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR ALPHA;

ADULT; ARTICLE; CIRCULATION; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; FEMALE; FLOW CYTOMETRY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOFLUORESCENCE TEST; MALE; MEDICAL RESEARCH; PERIPHERAL LYMPHOCYTE; PHAGOCYTE; ULCERATIVE COLITIS;

ADULT; ANTIGENS, CD; CASE-CONTROL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; INFLAMMATORY BOWEL DISEASES; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; PHAGOCYTES;

EID: 43149120711     PISSN: 13004948     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Podolsky DK. Inflammatory bowel disease (first of two parts). N Engl J Med 1991; 325: 928-37.
2. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995; 24: 475-507.
3. Sartor RB. Cytokines in intestinal inflammation: pathophysiological and clinical considerations. Gastroenterology 1994; 106: 533-9.
4. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998; 115: 182-205.
5. Schölmerich J. Inflammatory bowel disease. Endoscopy 1999; 31: 66-73.
6. Perlmann P, Broberger O. In vitro studies of ulcerative colitis. Cytotoxic action of white blood cells from patients on human fetal colon cells. J Exp Med 1963; 117: 717-33.
7. Pallone F, Fais S, Squarcia O, et al. Activation of peripheral blood and intestinal lamina propria lymphocytes in Crohn's disease. In vivo state of activation and in vitro response to stimulation as defined by the expression of early activation antigens. Gut 1987; 28: 745-53.
8. Saverymuttu SH, Camilleri M, Rees H, et al. Indium-111 granulocyte scanning in the assessment of disease extent and disease activity in inflammatory bowel disease. A comparison with colonoscopy, histology and fecal indium-111 granulocyte excretion. Gastroenterology 1986; 90: 1121-8.
9. MacDermott RP. Alterations in the mucosal immune system in ulcerative colitis and Crohn's disease. Med Clin North Am 1994; 78: 1207-31.
10. th ed. Philadelphia: W.B. Saunders, 1998; 19-48.
11. Madara JL, Sitaraman SV. Intestinal epithelial barrier function: characteristics and responses to neutrophil transepithelial migration. In: Sartor RB, Sandborn WJ, eds. Kirsner's inflammatory bowel diseases. New York: W.B. Saunders, 2004; 3-17.
12. Harvey RF, Bradshaw JM. A simple index of Crohn's disease activity. Lancet 1980; 1: 514.
13. Rachmilewitz D. Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis. BMJ 1989; 298: 82-6.
14. Auer IO, Wechsler W, Ziemer E, et al. Immune status in Crohn's disease. 1. Leukocytes and lymphocyte subpopulations in peripheral blood. Scand J Gastroenterol 1978; 13: 561-71.
15. Selby WS, Jewell DP. T lymphocyte subsets in inflammatory bowel disease: peripheral blood. Gut 1983; 24: 99-105.
16. Selby WS, Janossy G, Bofill M, Jewell DP. Intestinal lymphocyte subpopulations in inflammatory bowel disease: an analysis by immunohistological and cell isolation techniques. Gut 1984; 25: 32-40.
17. Parkos CA, Delp C, Arnaout MA, Madara JL. Neutrophil migration across a cultured intestinal epithelium: dependence on a CD11b/18-mediated event and enhanced efficiency in physiological direction. J Clin Invest 1991; 88: 1605-12.
18. Nakamura S, Ohtani H, Watanabe Y, et al. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells. Lab Invest 1993; 69: 77-85.
19. Mishra L, Mishra BB, Harris M, et al. In vitro cell aggregation and cell adhesion molecules in Crohn's disease. Gastroenterology 1993; 104: 772-9.
20. Burgio VL, Fais S, Boirivant M, et al Peripheral monocyte naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995; 109: 1029-38.
21. Meenan J, Spaans J, Grool TA, et al. Altered expression of α?4β7, a gut homing integrin, by circulating and mucosal T cells in colonic mucosal inflammation. Gut 1997; 40: 241-6.
22. + phenotype and defective proliferative response in T lymphocytes from patients with Crohn's disease. Gastroenterology 1996; 110: 1008-19.
23. + B cells in Crohn's disease correlates with intestinal permeability. Gastroenterology 1995; 108: 132-7.
24. Nielsen OH, Brynskov J, Vainer BIn. creased mucosal concentrations of soluble intercellular adhesion molecule-1 (sICAM-1), sE-selectin and interleukin-8 in active ulcerative colitis. Dig Dis Sci 1996; 41: 1780-5.
25. Liu ZX, Noguchi M, Hiwatashi N, Toyota T. Monocyte aggregation and multinucleated giant-cell formation in vitro in Crohn's disease. The effect of cell adhesion molecules. Scand J Gastroenterol 1996; 31: 706-10.